Express Scripts Holding (NASDAQ:ESRX) has been assigned an average recommendation of “Hold” from the twenty-four research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $81.45.
ESRX has been the subject of a number of research analyst reports. Deutsche Bank initiated coverage on Express Scripts in a research note on Monday, December 4th. They set a “buy” rating and a $75.00 price target for the company. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, December 4th. TheStreet raised Express Scripts from a “c+” rating to a “b-” rating in a research note on Monday, December 4th. Sanford C. Bernstein raised Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Wednesday, December 6th. Finally, BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Thursday, December 14th.
Shares of Express Scripts (ESRX) traded down $0.13 during trading on Friday, hitting $76.20. The stock had a trading volume of 3,584,164 shares, compared to its average volume of 5,280,534. The stock has a market cap of $42,840.00, a PE ratio of 9.86, a price-to-earnings-growth ratio of 0.94 and a beta of 0.94. The company has a current ratio of 0.67, a quick ratio of 0.55 and a debt-to-equity ratio of 0.83. Express Scripts has a 12-month low of $55.80 and a 12-month high of $85.07.
Express Scripts announced that its Board of Directors has authorized a share buyback plan on Monday, December 18th that permits the company to buyback 45,000,000 shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s leadership believes its stock is undervalued.
In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Everett Neville sold 4,895 shares of Express Scripts stock in a transaction on Thursday, March 1st. The shares were sold at an average price of $75.26, for a total value of $368,397.70. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,792 shares of company stock valued at $909,815. 0.68% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the business. SeaCrest Wealth Management LLC bought a new position in shares of Express Scripts in the 4th quarter worth $105,000. Bank of Nova Scotia Trust Co. bought a new position in shares of Express Scripts in the 3rd quarter worth $120,000. Aevitas Wealth Management Inc. bought a new position in shares of Express Scripts in the 4th quarter worth $128,000. Financial Gravity Companies Inc. bought a new position in shares of Express Scripts in the 4th quarter worth $142,000. Finally, Monroe Bank & Trust MI raised its position in shares of Express Scripts by 74.8% in the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after acquiring an additional 970 shares in the last quarter. 89.08% of the stock is owned by institutional investors and hedge funds.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.